Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lafeuillade

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Antiviral Therapy|May 1, 2001
A pilot study of a combination of three reverse transcriptase inhibitors in HIV-1 infectionA Lafeuillade, C Poggi, A Djediouane, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
HIV-1 induction-maintenance at the lymph node level: the "Apollo-97" StudyA Lafeuillade, C Poggi, S Chadapaud, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cellsA Lafeuillade, P Halfon, S Chadapaud, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 18, 2003
HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimenA Lafeuillade, C Solas, S Chadapaud, et al.
Presse Medicale (Paris, France : 1983)|May 1, 1993
[Intestinal ischemic manifestations related to cholesterol emboli?]R Quilichini, T Benderitter, A Lafeuillade, et al.
AIDS (London, England)|July 23, 1999
Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infectionC Poggi, N Profizi, A Djediouane, et al.
Lancet (London, England)|January 11, 1992
In-vitro activity of zidovudine against mycoplasmaA Lafeuillade, G Papierok, G Pautrat, et al.
Infection|May 1, 1994
Role of autoimmunity in protein S deficiency during HIV-1 infectionA Lafeuillade, M Sorice, T Griggi, et al.
Presse Medicale (Paris, France : 1983)|January 22, 1994
[Syndrome of hyperimmunoglobulinemia E in a HIV-1 seropositive patient. A new case]A Lafeuillade, P Pellegrino, M Savoye, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Evolution of lipid abnormalities in patients switched from stavudine- to tenofovir-containing regimensA Lafeuillade, P Jolly, S Chadapaud, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Antiviral Therapy|May 1, 2001
A pilot study of a combination of three reverse transcriptase inhibitors in HIV-1 infectionA Lafeuillade, C Poggi, A Djediouane, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
HIV-1 induction-maintenance at the lymph node level: the "Apollo-97" StudyA Lafeuillade, C Poggi, S Chadapaud, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cellsA Lafeuillade, P Halfon, S Chadapaud, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 18, 2003
HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimenA Lafeuillade, C Solas, S Chadapaud, et al.
Presse Medicale (Paris, France : 1983)|May 1, 1993
[Intestinal ischemic manifestations related to cholesterol emboli?]R Quilichini, T Benderitter, A Lafeuillade, et al.
AIDS (London, England)|July 23, 1999
Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infectionC Poggi, N Profizi, A Djediouane, et al.
Lancet (London, England)|January 11, 1992
In-vitro activity of zidovudine against mycoplasmaA Lafeuillade, G Papierok, G Pautrat, et al.
Infection|May 1, 1994
Role of autoimmunity in protein S deficiency during HIV-1 infectionA Lafeuillade, M Sorice, T Griggi, et al.
Presse Medicale (Paris, France : 1983)|January 22, 1994
[Syndrome of hyperimmunoglobulinemia E in a HIV-1 seropositive patient. A new case]A Lafeuillade, P Pellegrino, M Savoye, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Evolution of lipid abnormalities in patients switched from stavudine- to tenofovir-containing regimensA Lafeuillade, P Jolly, S Chadapaud, et al.
Pageof 10